Local Institution

Cracow 31-202

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome (ACS), Bladder Cancer, Metastasis, Transitional Cell Carcinoma

Studies at this site

• Safety Study of Apixaban in Recent Acute Coronary Syndrome — Completed
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed